Finance

Lists
301277:SHE
Newland Pharmaceutical Co Ltd
CNÂ¥10.04
-1.28%
(-0.13) 1D
Oct 16, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301277...
Open
CNÂ¥10.24
High
CNÂ¥10.59
Low
CNÂ¥9.98
Mkt. cap
3.94B
Avg. vol.
3.33M
Volume
3.66M
Dividend
1.99%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Apr 30, 2026
P/E ratio
37.86
52-wk high
CNÂ¥13.84
52-wk low
CNÂ¥8.45
EPS
CNÂ¥0.27
Shares outstanding
392.08M
No. of employees
981
Open
CNÂ¥10.24
High
CNÂ¥10.59
Low
CNÂ¥9.98
Mkt. cap
3.94B
Avg. vol.
3.33M
Volume
3.66M
Dividend
1.99%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Apr 30, 2026
P/E ratio
37.86
52-wk high
CNÂ¥13.84
52-wk low
CNÂ¥8.45
EPS
CNÂ¥0.27
Shares outstanding
392.08M
No. of employees
981
News stories
From web sources and news partners
About Newland Pharmaceutical Co Ltd
CEO-
Employees981
FoundedSep 15, 2005
Headquarters-
SectorPharmaceutical industry
Websitenewlandpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
122.43M
191.14M
206.95M
190.03M
Cost of goods sold
83.98M
138.56M
141.52M
143.54M
Cost of revenue
83.98M
138.56M
141.52M
143.54M
Research and development expenses
8.33M
9.79M
6.86M
9.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.48M
16.44M
14.66M
13.83M
Operating expense
22.06M
29.05M
23.97M
25.68M
Total operating expenses
106.04M
167.61M
165.49M
169.23M
Operating income
16.38M
23.53M
41.45M
20.80M
Other non operating income
2.67M
-2.69M
-123.00K
93.63K
EBT including unusual items
15.44M
31.34M
41.72M
27.27M
EBT excluding unusual items
21.71M
22.93M
42.86M
23.81M
Income tax expense
2.11M
2.54M
5.95M
2.96M
Effective tax rate
13.69%
8.12%
14.25%
10.84%
Other operating expenses
1.33M
531.26K
1.86M
1.22M
Net income
13.87M
29.35M
36.10M
24.67M
Net profit margin
11.33%
15.35%
17.44%
12.98%
Earnings per share
-
-
-
-
Interest and investment income
2.70M
2.18M
1.57M
3.05M
Interest expense
-51.38K
-48.10K
-34.88K
-23.86K
Net interest expenses
2.65M
2.13M
1.53M
3.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
25.16M
36.67M
54.59M
37.12M
Gain or loss from assets sale
-466.62K
-
-
-235.40K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps